450
X. Li et al. / Journal of Molecular Catalysis A: Chemical 363–364 (2012) 446–450
Table 3 (Continued)
COOEt
R1
R2
NHTs
COOEt
COOEt
R1
COOEt
COOEt
KOH (20 mol%)
acetone, 35oC
R1
R2
N
Ts
+
COOEt
NHTs
+
R2
1
2a
3
4
Entry
N-tosylaziridine
Product
t [h]
Yieldb [%]
cRatio 3:4
COOEt
N-Ts
CH
EtOOC
NHTs
14
4n
21
73
–
N-Ts
COOEt
CH
EtOOC
NHTs
15
16
4o
4p
36
20
72
–
COOEt
N-Ts
CH
O2N
EtOOC
O2N
NHTs
Trace
COOEt
COOEt
NH-Ts
N-Ts
s
s
17
3q
21
83
95:5
a
Unless otherwise specified, all reactions were carried out with N-tosylaziridine 1 (0.2 mmol), diethyl malonate 2a (304 L, 2 mmol, 10 equiv.), catalyst (KOH, 2.3 mg,
20 mol%) and acetone (1.5 mL) under air atmosphere at 35 ◦C for the identified time.
b
Isolated yield.
Combined yield of isolated 3 and 4.
c
d
These compounds gave two isomer products that could not be separated by column chromatography and HPLC, and their ratios were determined by 1H NMR.
4. Conclusions
(c) R.M. Williams, Tetrahedron Lett. 35 (1994) 9371;
(d) T. Maegawa, Amino Acids 36 (2009) 493.
[6] (a) M. Otsuka, J. Am. Chem. Soc. 112 (1990) 838;
(b) L.D.S. Yadav, A. Rai, Tetrahedron Lett. 49 (2008) 5751;
(c) A. Sasi, Asian J. Microbiol. Biotechnol. Environ. Sci. 11 (2009) 185.
[7] Z. Zhang, J. Labelled Compd. Radiopharm. 45 (2002) 199.
[8] A.B. Holmes, J. Chem. Soc. Perkin Trans. 1 (1991) 3301.
[9] (a) F. Köhler, H. Gais, G. Raabe, Org. Lett. 9 (2007) 1231;
(b) A.R. Katritzky, H. Tao, R. Jiang, K. Suzuki, K. Kirichenko, J. Org. Chem. 72
(2007) 407.
In conclusion, KOH, which is a low-cost and environmentally
friendly reagent, is found to be an excellent base catalyst for the
ring-opening reactions of N-tosylaziridines with diethyl malonate
under mild conditions in acetone. Wide substrate scope, mild con-
ditions, and simple handling are advantages of this procedure. More
importantly, it provides a feasible direction of the ring-opening
reaction for N-tosylaziridines with active methylene nucleophiles.
[10] (a) M. Winkler, A.C. Knall, M.R. Kulterer, N. Klempier, J. Org. Chem. 72 (2007)
7423;
(b) P. Wipf, C.R.J. Stephenson, Org. Lett. 7 (2005) 1137;
(c) J. Deng, X.P. Hu, J.D. Huang, S.B. Yu, D.Y. Wang, Z.C. Duan, Z. Zheng, J. Org.
Chem. 73 (2008) 6022;
Appendix A. Supplementary data
(d) V. Capriati, L. Degennaro, S. Florio, R. Luisi, P. Punzi, Org. Lett. 8 (2006) 6147;
(e) J. Deng, Z.C. Duan, J.D. Huang, X.P. Hu, D.Y. Wang, S.B. Yu, X.F. Xu, Z. Zheng,
Org. Lett. 9 (2007) 4825.
Supplementary data associated with this article can be
[11] (a) Y.G. Chi, L. Guo, N.A. Kopf, S.H. Gellman, J. Am. Chem. Soc. 130 (2008) 5608;
(b) L. Guo, Y.G. Chi, A.M. Almeida, I.A. Guzei, B.K. Parker, S.H. Gellman, J. Am.
Chem. Soc. 131 (2009) 16018;
(c) L.T. Shen, L.H. Sun, S. Ye, J. Am. Chem. Soc. 133 (2011) 15894.
[12] Y.J. Xu, L.Q. Lin, M. Kanai, S. Matsunaga, M. Shibasaki, J. Am. Chem. Soc. 133
(2011) 5791.
[13] M.K. Ghorai, D.P. Tiwari, J. Org. Chem. 75 (2010) 6173.
[14] E.V. Blyumin, H.J. Gallon, A.K. Yudin, Org. Lett. 9 (2007) 4677.
[15] P.W. Smith, A.R. Whittington, K.N. Cobley, A. Jaxa-Chamiec, H. Finch, J. Chem.
Soc. Perkin Trans. 1 (2001) 21.
References
[1] J.S. Bryans, D.J. Wustrow, Med. Res. Rev. 19 (1999) 149.
[2] J.R. Cooper, F.E. Bloom, R.H. Roth, The Biochemical Basis of Neuropharmacology,
Oxford Press, Oxford, 2003.
[3] D.M. Tassone, E. Boyce, J. Guyer, D. Nuzum, Clin. Ther. 29 (2007) 26.
[4] S. Gracia, Tetrahedron Lett. 51 (2010) 6290.
[16] M.F.Z. Page, S.S. Jalisatgi, A. Maderna, M.F. Hawthorne, Synthesis (2008)
555.
[5] (a) F. Palacios, Tetrahedron 57 (2001) 3131;
(b) B.M. Trost, J. Am. Chem. Soc. 122 (2000) 5968;